Genmab — December 2021
-
God morgen.
-
Asien: Let positive markeder med svag omsætning https://www.proinvestor.com/investornyt/752906/asien-let-positive-markeder-med-svag-omsaetning
-
Onsdagens aviser med Danske Bank, Aarsleff og Velux
https://www.proinvestor.com/investornyt/752905/onsdagens-aviser-med-danske-bank-aarsleff-og-velux -
TA investerings case stadig intakt. Som det ses på kortet tog det kun 2 dage fra ca. 2750 til 2500 så det bliver spændende, at se kommende handelsdage hvor meget modstand der er i området op til de 2750 eller højere https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/99621_Skaermbillede_2021_12_22_140540_intakt.jpg
-
Daratumumab and venetoclax in combination with chemotherapy provide sustained molecular remission in relapsed/refractory CD19, CD20, and CD22 negative acute B lymphoblastic leukemia https://biomarkerres.biomedcentral.com/articles/10.1186/s40364-021-00343-3
-
Aktier/tendens: Mærsk tager fokus med opkøb til 24 mia. kr. https://www.proinvestor.com/investornyt/752933/aktier-tendens-maersk-tager-fokus-med-opkob-til-24-mia-kr
-
Darzalex recepttal november USD 344M. Subcu udgør ca. 75%. Rybrevant salg var 4.46M i november.
-
Aktier/middag: Mærsk-aktien vugger om nulpunktet trods millardopkøb https://www.proinvestor.com/investornyt/752985/aktier-middag-maersk-aktien-vugger-om-nulpunktet-trods-millardopkob
-
NICE (NOT China
) Appraisal Document Daratumumab plus bortezomib, thalidomide and dexamethasone 'is recommended only if the
company provides daratumumab according to the commercial
arrangement' https://www.nice.org.uk/guidance/gid-ta10449/documents/html-content-5?utm_medium=social&utm_source=twitter&utm_campaign=daratumumab1510fad -
U.S. Stocks Remain Mostly Positive In Afternoon Trading https://www.proinvestor.com/investornyt/753317/us-stocks-remain-mostly-positive-in-afternoon-trading
-
God morgen.
-
Asien: Globale stigninger fortsætter i asiatisk handel https://www.proinvestor.com/investornyt/753536/asien-globale-
stigninger-fortsaetter-i-asiatisk-handel -
Torsdagens aviser med Mærsk, Bavarian og Novo Nordisk https://www.proinvestor.com/investornyt/753535/torsdagens-aviser-med-maersk-bavarian-og-novo-nordisk
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind